Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

The Lancet (2010) - Comments
doi: 10.1016/s0140-6736(10)60746-5 issn: 0140-6736 pubmed: 20605202

Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony JG Hanley